GLSI
GreenwichยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GLSI Profile
Greenwich Lifesciences, Inc.
A clinical-stage biopharmaceutical company that develops breast cancer immuno therapies to prevent the recurrence of breast cancer following surgery
Pharmaceutical
08/29/2006
09/25/2020
NASDAQ Stock Exchange
4
12-31
Common stock
3992 Bluebonnet Dr, Building 14, Stafford, TX 77477
--
Greenwich LifeSciences, Inc., established on August 29, 2006, is a Delaware corporation. The company, a biopharmaceutical company, is developing GP 2, an immunotherapy designed to prevent postoperative breast cancer recurrence.
